Physician profile
Erin E Sievers
NPI 1518315415
$2,741.16
in general payments reported to CMS, 2019-2025
36 companies · $874 in 2025
The $874 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.26 · 2022: $253 · 2023: $667 · 2024: $897 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,438.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $506.31 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $316.75 | 2023-2025 | |
| Amgen INC. | $247.92 | 2022-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $218.29 | 2022-2025 | Mounjaro, Jardiance, Trulicity |
| Glaxosmithkline, LLC. | $173.67 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $149.96 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.53 | 2021-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.92 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $78.68 | 2024-2025 | |
| Braintree Laboratories, INC. | $73.08 | 2022-2025 | Suflave, Sutab |
| Viatris Specialty LLC | $65.78 | 2025 | Yupelri |
| Mylan Specialty L.P. | $59.17 | 2023-2024 | Yupelri |
| Inari Medical, INC. | $58.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $57.61 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $52.30 | 2021-2024 | Airsupra |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $49.07 | 2023-2024 | Rexulti, Abilify Maintena |
| Verona Pharma, INC. | $46.99 | 2025 | Ohtuvayre |
| Ardelyx, INC. | $46.84 | 2024-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.20 | 2023-2025 | Xifaxan, Trulance |
| Corium, LLC | $41.30 | 2023-2024 | Azstarys |
| Astellas Pharma US INC | $28.71 | 2024 | Veozah |
| Exact Sciences Corporation | $28.01 | 2024-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $21.74 | 2024 | Nexletol |
| Biogen, INC. | $18.65 | 2025 | Zurzuvae |
| Ironshore Pharmaceuticals INC. | $16.52 | 2024 | |
| Merck Sharp & Dohme LLC | $15.67 | 2023 | Proquad, Vaxneuvance, Gardasil 9 |
| Radius Health, INC. | $15.58 | 2025 | Tymlos |
| Stryker Corporation | $15.33 | 2025 | Clottriever Bold Catheter |
| Phathom Pharmaceuticals, INC. | $15.22 | 2024 | Voquezna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.54 | 2023 | |
| Lundbeck LLC | $13.98 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $13.60 | 2022 | |
| Inspire Medical Systems, INC. | $13.48 | 2025 | Inspire |
| Eisai INC. | $12.84 | 2022 | |
| Xeris Pharmaceuticals, INC. | $12.48 | 2022 | |
| Organon LLC | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Sievers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.